{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:49:09Z","timestamp":1792136949077,"version":"4.4.0"},"reference-count":0,"publisher":"Dustri-Verlag Dr. Karl Feistle","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2026,11,1]]},"DOI":"10.5414\/cp205008","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:35:04Z","timestamp":1788424504000},"page":"591-599","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacotherapy of heart failure: Impact of the 2021 guideline update on guideline-directed medical therapy assessed using a Japanese employee health insurance claims database"],"prefix":"10.5414","volume":"64","author":[{"given":"Takaya","family":"Uno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:17:04Z","timestamp":1792135024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=193191&doi=10.5414\/CP205008&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["205008"],"URL":"https:\/\/doi.org\/10.5414\/cp205008","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}